Preliminary Study of Inhibitory Effects of Hapten 2,4dinitrofluorobenzene on Hepatocellular Carcinoma in Vitro and in Vivo

李开春,袁振刚,戴兆云

2013-01-01

Abstract:[Purpose] To investigate inhibitory effect of hapten 2,4-dinitrofluorobenzene(2,4DNFB) on hepatocellular carcinoma(HCC) in vitro and in vivo.[Methods] SMMC-7721 cells were treated with DNFB and 5-fluorouracil(5-Fu)(control group) under different concentrations for 72 hours.The methyl thiazolyl tetrazolium(MTT) method was used to determine survival rate of HCC cells,and to calculate IC50 and IC90.Eighteen Kunming mice,of which H22 cells were successfully implanted into subcutaneousness,were randomly divided into three groups,DNFB group,Ethanol group and PBS group(control group),and 100μl DNFB,ethanol and PBS were intra-tumor rally injected in each group,twice a week for two weeks,respectively.After two weeks,the tumor were weighted and the rates of tumor inhibition(RTI) were calculated.[Results] Contrations of DNFB and 5-Fu to reach IC50 of SMMC-7721 cells were 32.22μmol/L and 3.62μmol/L respectively,and those to reach IC90 were 49.53μmol/L and 200μmol/L,respectively.The tumor weights in DNFB group,Ethanol group and PBS control group were 0.97±0.53g,1.55 ±0.76g and 3.79 ±0.75g,respectively.Compared with PBS control group,the RTI was 74.43% in DNFB group(P=0.00004) and 59.20% in Ethanol group(P=0.00045),but there was no statistically difference between DNFB group and Ethanol group(P=0.16).[Conclusion] Hapten DNFB can inhibit HCC growth in vitro and in vivo.